Subscribe for the Newsletter

Mobile Navigation

Leveraging AI and RNA to Fight Rare Diseases

Envisagenics

Envisagenics

Feb 24, 2022PAO-02-22-R250-17

Along the Road to 50 States, Dr. Martin Akerman, Co-Founder and CTO at Envisagenics, talks to Nigel about the company's approach of combining AI technology and RNA to fight rare diseases and improve patients' lives around the world.

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.